Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.
about
Targeting the biophysical properties of the myeloma initiating cell niches: a pharmaceutical synergism analysis using multi-scale agent-based modelingMutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drugA novel monoclonal anti-CD81 antibody produced by genetic immunization efficiently inhibits Hepatitis C virus cell-cell transmissionActivity of oxantel pamoate monotherapy and combination chemotherapy against Trichuris muris and hookworms: revival of an old drugSynergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expressionSelective Targeting of CTNBB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing DrugsCodelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity.NCTD promotes Birinapant-mediated anticancer activity in breast cancer cells by downregulation of c-FLIP.Differential effect of artemisinin against cancer cell lines.Blockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibitionGenome-wide DNA methylation profiling of CpG islands in a morpholino anthracycline derivative-resistant leukemia cell line: p38α as a novel candidate for resistance.Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.Comparison of methods for evaluating drug-drug interaction.Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.Additive in vitro antiplasmodial effect of N-alkyl and N-benzyl-1,10-phenanthroline derivatives and cysteine protease inhibitor e64.Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.1'-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations.HGF rescues colorectal cancer cells from EGFR inhibition via MET activationTherapeutic potential and molecular mechanism of a novel, potent, nonpeptide, Smac mimetic SM-164 in combination with TRAIL for cancer treatmentSynergistic growth inhibition by acyclic retinoid and phosphatidylinositol 3-kinase inhibitor in human hepatoma cells.The PI-3 kinase-Akt-MDM2-survivin signaling axis in high-risk neuroblastoma: a target for PI-3 kinase inhibitor intervention.Suberoyl bis-hydroxamic acid enhances cytotoxicity induced by proteasome inhibitors in breast cancer cells.Study of the cytotoxic effects of the new synthetic Isothiocyanate CM9 and its fullerene derivative on human T-leukemia cells.Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C.The role of AXL and the in vitro activity of the receptor tyrosine kinase inhibitor BGB324 in Ewing sarcomaEtoposide incorporated into camel milk phospholipids liposomes shows increased activity against fibrosarcoma in a mouse modelGamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells.Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model.Conjugated polymer and drug co-encapsulated nanoparticles for chemo- and photo-thermal combination therapy with two-photon regulated fast drug release.HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCLSynergy between inhibitors of androgen receptor and MEK has therapeutic implications in estrogen receptor-negative breast cancer.XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A.Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancerRecombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors.Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapyXI-006 induces potent p53-independent apoptosis in Ewing sarcoma.Combination of α-Tomatine and Curcumin Inhibits Growth and Induces Apoptosis in Human Prostate Cancer Cells
P2860
Q27334339-05977617-3EDA-481E-A558-96D23D005C8FQ27851423-8EDFEDCE-3804-4A69-BA2E-C7275C36F75DQ28478861-48B754A1-3E7E-40E6-9E7A-CF6C12888097Q28488372-01C3034D-C757-421C-B8E2-CD382B3844DAQ28488644-782C8387-A084-4D3D-9A3D-3E7CAC2CD3FCQ28542871-4133FBE4-2887-4591-9D10-C217539FE8E4Q28547522-1417BBFD-5546-444F-B94C-C1359FC4F3C4Q33598842-CCEEF6EB-4B6B-47C5-A037-F336807170F9Q33688860-6A94AA1A-7930-4A03-B03A-9A42FC3F49EAQ33729505-BD05B060-5F85-49A3-8254-27CDCDC3F161Q33732534-F608D734-0005-4040-AF8D-D62FD8A7DFA7Q33751271-D2552B0B-D269-4B27-B744-DA504C1505D2Q33771409-17E538A2-0FAF-451A-8781-FBB7C7CD421FQ33851448-5D458E7A-02D4-4D62-967C-C490587B6342Q33914266-E1970BF8-5FAA-47C7-83E0-009F2A754717Q34063560-DB0DC39E-9E30-4C34-B6BD-9ABB1272CED2Q34079286-EFA0ECF9-0765-4534-8ED7-C8386EFD2DE2Q34158257-6D34A8EF-0642-4E17-9E4A-DFD7AC8C884EQ34420112-D393452B-2ADF-4F41-9B63-26061AAA9DCBQ34436147-8AFC27DB-796A-4371-9C62-A3E34901EEC6Q34550898-036C4C46-F281-457C-8F4E-C76F7873117FQ34970050-C4488935-A80F-430C-9FCD-3D516E09C238Q35011302-001D8915-FE8F-490E-83FB-CBB932715293Q35127189-560CC87E-37DA-4DC6-AD2C-892D0652A9C2Q35128130-7B5510D7-C3D9-4024-B7E4-BB390368AC1AQ35131562-2192D0DD-D9E4-4849-B853-85716AD343C1Q35135565-0D1A0C4C-83F7-4AED-9B5B-78BF86D5883FQ35149569-DB1B45F9-27A5-44AB-A0A2-DE07DC1F095EQ35187801-0AFC2479-BAC9-438D-9CE8-5DB0ACC87E90Q35198623-0CE33003-DD5B-4A07-9CB5-CC9E46098BC4Q35491314-DE01312A-5473-4DDD-87FF-7AE85EFC0EF2Q35546710-FF3A5805-6D21-485A-BF88-D7357B21E8D4Q35553330-AEEBB390-904C-4C63-B94F-0455B4DC2893Q35558993-7AA534C3-7081-4D09-8B89-1BBAB77E5C32Q35602930-0D11FA8E-E4E3-442C-BEC3-5EA026B31982Q35618447-B12E09E9-43FA-4820-B72C-942ED87F22B9Q35687188-4A757711-70B3-4875-A6EE-FE94A650A0E9Q35746919-2BD9DF64-3CFB-44E9-B131-D78C970508AEQ35764901-C8E56F3C-F160-4F99-BDEF-3C6CA53EF414Q35858905-D9496136-67A3-470B-B4E0-CE91EC9EB821
P2860
Evaluation of combination chemotherapy: integration of nonlinear regression, curve shift, isobologram, and combination index analyses.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Evaluation of combination chem ...... nd combination index analyses.
@en
Evaluation of combination chem ...... nd combination index analyses.
@nl
type
label
Evaluation of combination chem ...... nd combination index analyses.
@en
Evaluation of combination chem ...... nd combination index analyses.
@nl
prefLabel
Evaluation of combination chem ...... nd combination index analyses.
@en
Evaluation of combination chem ...... nd combination index analyses.
@nl
P2093
P1476
Evaluation of combination chem ...... nd combination index analyses.
@en
P2093
Jessie L-S Au
Liang Zhao
M Guillaume Wientjes
P304
P356
10.1158/1078-0432.CCR-04-1087
P407
P577
2004-12-01T00:00:00Z